Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine for prehospital acute pain
NCT02753114Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Nov 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute pain comparing Intranasal Ketamine with Placebo (2 arms). Primary endpoint: Proportion experiencing 2-point or more pain score reduction at 30 minutes. Started Nov 2017; status: completed.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02753114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02753114.